Imatinib Completed Phase 1 Trials for Leukemia,Myeloid, Chronic Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00040105Zarnestra and Gleevec in Chronic Phase Chronic Myelogenous Leukemia